Nano-X Imaging (NNOX) Current Deferred Revenue (2021 - 2026)

Nano-X Imaging (NNOX) has reported Current Deferred Revenue for 6 consecutive years, with $454000.0 the latest figure, recorded in Q1 2026.

• For the quarter ending Q1 2026, Current Deferred Revenue rose 305.36% year-over-year to $454000.0; the trailing twelve-month figure through Mar 2026 stood at $454000.0 (up 305.36% YoY), and the FY2025 full-year result was $534000.0, up 281.43% from the prior year.
• Current Deferred Revenue eased to $454000.0 in Q1 2026 per NNOX's latest filing, from $534000.0 in the prior quarter.
• Across five years, Current Deferred Revenue topped out at $626.0 million in Q3 2022 and bottomed at $112000.0 in Q1 2025.
• Historically, Current Deferred Revenue has averaged $37.2 million across 5 years, with a median of $456000.0 in 2023.
• The sharpest annual moves came in 2023 and 2026: Current Deferred Revenue plunged 99.92% in 2023, then surged 305.36% in 2026.
• Over 5 years, Current Deferred Revenue stood at $580000.0 in 2022, then declined by 6.38% to $543000.0 in 2023, then plunged by 74.22% to $140000.0 in 2024, then surged by 281.43% to $534000.0 in 2025, then dropped by 14.98% to $454000.0 in 2026.
• According to Business Quant data, Current Deferred Revenue over the past three periods registered $454000.0, $534000.0, and $273000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.